Search for content, post, videos

Acturum takes over AstraZeneca facilities

AstraZeneca’s facility Snäckviken in Södertälje has been acquired by Acturum and will from now on be called BiovationPark Telge. The facility will host SP process development, Scania, Campus Telge and around 20 small research companies.
Besides laboratories and offices, Acturum will install 5000 laboratory instruments at the facility. Astra will also hand over 15 drug development projects in neuroscience and pain research as part of the deal. Acturum is owned by PEAB and FAM-Foundation Asset Management. The facilities cover 130 000 square meters.